CVS Group plc, a leading provider of integrated veterinary services in the UK and Australia, has confirmed that certain employees exercised options under the CVS Group 2020 SAYE Plan, resulting in the issuance of 11,345 ordinary shares of 0.2 pence each. The issuance was partially satisfied by shares held by the CVS Group Employee Benefit Trust, leaving the trust with approximately 0.0002% of the Company's total voting rights.
Additionally, 10,864 new Ordinary Shares were issued to satisfy the balance of shares arising from the SAYE Exercise. Following this, the Company's total issued share capital stands at 71,732,133 Ordinary Shares, with no shares held in treasury, resulting in a total of 71,732,133 voting rights.
This figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
CVS Group plc operates approximately 460 veterinary practices, including specialist referral hospitals and dedicated out-of-hours sites, alongside Laboratories, Crematoria, and an online retail business. The company is focused on providing high-quality clinical services to its clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy.
For further information, shareholders can contact CVS Group plc or its appointed advisors.